A class action lawsuit has been filed against Ardent Health, Inc. alleging the company reported inflated accounts receivable and delayed loss recognition during the period spanning July 18, 2024 through November 12, 2025. The litigation comes after Ardent disclosed a $43 million revenue decline in the third quarter of 2025 following the implementation of a new accounting system, which prompted a significant market correction in the company's stock price.
Following the revenue restatement announcement, Ardent Health shares declined 34 percent, falling from $14.05 to $9.30 per share. The sharp equity decline reflects investor concerns regarding the company's accounting practices and the magnitude of previously undisclosed financial pressures. Law firm Bragar Eagel & Squire, P.C. is representing shareholders in the action and has established March 9, 2026 as the deadline for investors to apply for lead plaintiff status in the litigation.
Ardent Health shareholders who held securities during the class period and believe they have been harmed by the accounting irregularities should review their legal options through their counsel or contact the firms representing the class action. The outcome of this case may have material implications for the company's financial reporting and investor confidence moving forward.